Top Picks Playlist
Listen and watch Zeus’ analysts as they present their top picks for 2024.
View the full research note: Top Picks for 2024.
Arrow Exploration
Equals Group
Gooch & Housego
Intercede Group
Marshalls
Nexteq
Norcros
Pendragon
PetroTal
Arrow Exploration
Arrow is an E&P company focused onshore Colombia, with net production of over 3.2mboe/d as of end 2023. The company executed an 11 well 2023 work programme, which added material reserves and production from its Rio Cravo Este and Carrizales Norte fields, and is planning another 15 wells in 2024, all funded from cash flows.
View the full research note: Top Picks for 2024.
Equals Group
In 2023 Equals’ share price rose 36%, while its revenue rose by 36%, gross profit rose by >48%, and consensus forecasts were raised on numerous occasions. In 2024, we expect news flow to reflect well on both the quality and quantity of Equals’ streams of revenue and cashflow. In 2022 and 2023 growth was largely organic: In 2024 the acquisitions made in early 2023 should add to growth.
View the full research note: Top Picks for 2024.
Gooch & Housego
Recovery at Gooch is accelerating. December full year results were in line with our estimates with revenue up 19% and operating profit 28%. Profit improvement spanned all three verticals – Industrials, Aerospace & Defence and Life Sciences; the basics, postCOVID, have been fixed. The next step is to lift margins and returns, which are too low, in our view.
View the full research note: Top Picks for 2024.
Intercede Group
Intercede is the leading digital identity specialist in the authentication software market. The company is a led by a proven management team and benefits from high-growth markets, primarily driven by regulation. We expect the company to outperform conservative earnings expectation and valuation multiples to rise as the company delivers continued double digit revenue growth and expanding margins.
View the full research note: Top Picks for 2024.
Marshalls
Marshalls went into the downturn post the strategic acquisition of Marley Roofing. The rationale for the deal seemed obvious, it diversified the business, allowed for cross selling opportunities, and offered significant synergies.
View the full research note: Top Picks for 2024.
Nexteq
Nexteq is a well-managed technology provider with growing end markets and a resilient business model. Yet the company’s valuation multiples are near five-year lows (4.7x EBITDA 2024).
View the full research note: Top Picks for 2024.
Norcros
Norcros was one of our top picks 2023 and whilst the shares did not get the rerating we argued it deserved they did perform relatively well due to the strength of the operational execution in what was a very difficult year. The company remains a top pick for 2024 due to its discount to peers, despite long term margin expansion within the UK, its ability to win market share and, hopefully, a gradually improving operating environment that will highlight the undervaluation of the South Africa business.
View the full research note: Top Picks for 2024.
Pendragon
Pendragon is disposing of its UK motor retail and leasing businesses to US dealer group Lithia and transitioning to a pure-play SaaS business with its Pinewood dealership management system (DMS) product suite. Subject to completing at the end of January, the deal will see c. 24.5p distributed to shareholders in Q1/Q2 2024 and Lithia subscribing to 16.6% of shares in the ongoing listed entity, leaving existing holders with 83.3%.
View the full research note: Top Picks for 2024.
PetroTal
PetroTal is an E&P with production onshore Peru. The company holds 100% in the Bretana field, and achieved production of 14.0mbbl/d for Q1-Q3 2023. This is generating significant cash flows, allowing ongoing CAPEX investment, full retirement of the company’s debt, and a dividend implying a yield of at least 10%.
View the full research note: Top Picks for 2024.
Listen to all episodes of the Zeus Research team Audio Notes here.
This content is issued by Zeus Capital Limited (“Zeus”) (Incorporated in England & Wales No. 4417845), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority (“FCA”) for designated investment business, (Reg No. 224621) and is a member firm of the London Stock Exchange. This content is for information purposes only and neither the information contained, nor the opinions expressed, within constitute or are to be construed as an offer or a solicitation of an offer to buy or sell the securities or other instruments mentioned in it. Zeus shall not be liable for any direct or indirect damages, including lost profits arising in any way from the information contained in this material. This material is for the use of intended recipients only.
Contact
If you would like further information, please get in touch with our team.